These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 35761500)

  • 21. Chronic antidepressant treatment accelerates kindling epileptogenesis in rats.
    Cardamone L; Salzberg MR; Koe AS; Ozturk E; O'Brien TJ; Jones NC
    Neurobiol Dis; 2014 Mar; 63():194-200. PubMed ID: 24321434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effectiveness of antidepressants in the treatment of chronic non-cancer pain--a review].
    Miller A; Rabe-Jabłońska J
    Psychiatr Pol; 2005; 39(1):21-32. PubMed ID: 15771151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Use of Antidepressant Medications During Pregnancy and the Risk of Neonatal Seizures: A Systematic Review.
    Uguz F
    J Clin Psychopharmacol; 2019; 39(5):479-484. PubMed ID: 31425466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidepressant use and risk of adverse outcomes in older people: population based cohort study.
    Coupland C; Dhiman P; Morriss R; Arthur A; Barton G; Hippisley-Cox J
    BMJ; 2011 Aug; 343():d4551. PubMed ID: 21810886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative efficacy and acceptability of antidepressant treatment in poststroke depression: a multiple-treatments meta-analysis.
    Sun Y; Liang Y; Jiao Y; Lin J; Qu H; Xu J; Zhao C
    BMJ Open; 2017 Aug; 7(8):e016499. PubMed ID: 28775189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demographic and clinical factors associated with different antidepressant treatments: a retrospective cohort study design in a UK psychiatric healthcare setting.
    Fernandes AC; Chandran D; Khondoker M; Dewey M; Shetty H; Dutta R; Stewart R
    BMJ Open; 2018 Sep; 8(9):e022170. PubMed ID: 30185574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Should antidepressant drugs of the selective serotonin reuptake inhibitor family be tested as antiepileptic drugs?
    Hamid H; Kanner AM
    Epilepsy Behav; 2013 Mar; 26(3):261-5. PubMed ID: 23395350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin reuptake inhibitors and breastfeeding: a systematic review.
    Orsolini L; Bellantuono C
    Hum Psychopharmacol; 2015 Jan; 30(1):4-20. PubMed ID: 25572308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Escitalopram versus other antidepressive agents for depression.
    Cipriani A; Santilli C; Furukawa TA; Signoretti A; Nakagawa A; McGuire H; Churchill R; Barbui C
    Cochrane Database Syst Rev; 2009 Apr; (2):CD006532. PubMed ID: 19370639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Managing epilepsy-associated depression: Serotonin enhancers or serotonin producers?
    Singh T; Goel RK
    Epilepsy Behav; 2017 Jan; 66():93-99. PubMed ID: 28038393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spotlight on the pharmacoeconomics of escitalopram in depression.
    Croom KF; Plosker GL
    CNS Drugs; 2004; 18(7):469-73. PubMed ID: 15139801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT.
    Kessler D; Burns A; Tallon D; Lewis G; MacNeill S; Round J; Hollingworth W; Chew-Graham C; Anderson I; Campbell J; Dickens C; Macleod U; Gilbody S; Davies S; Peters TJ; Wiles N
    Health Technol Assess; 2018 Nov; 22(63):1-136. PubMed ID: 30468145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism.
    Preskorn SH
    Clin Pharmacokinet; 1997; 32 Suppl 1():1-21. PubMed ID: 9068931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The treatment of depressive disorders in epilepsy: what all neurologists should know.
    Kanner AM
    Epilepsia; 2013 Mar; 54 Suppl 1():3-12. PubMed ID: 23458461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents.
    Papakostas GI; Thase ME; Fava M; Nelson JC; Shelton RC
    Biol Psychiatry; 2007 Dec; 62(11):1217-27. PubMed ID: 17588546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Depression in epilepsy: symptom or syndrome?].
    Paciello N; Mazza M; Mazza S
    Clin Ter; 2002; 153(6):397-402. PubMed ID: 12645397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the direct costs and cost effectiveness of serotonin reuptake inhibitors and associated adverse drug reactions.
    Sullivan PW; Valuck R; Saseen J; MacFall HM
    CNS Drugs; 2004; 18(13):911-32. PubMed ID: 15521793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of antidepressants in depression: A systematic review and meta-analysis.
    Yuan Z; Chen Z; Xue M; Zhang J; Leng L
    J Clin Neurosci; 2020 Oct; 80():169-181. PubMed ID: 33099342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database.
    Coupland CA; Dhiman P; Barton G; Morriss R; Arthur A; Sach T; Hippisley-Cox J
    Health Technol Assess; 2011 Aug; 15(28):1-202, iii-iv. PubMed ID: 21810375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of antidepressants on the severity of COVID-19 in hospitalized patients: A systematic review and meta-analysis.
    Nakhaee H; Zangiabadian M; Bayati R; Rahmanian M; Ghaffari Jolfayi A; Rakhshanderou S
    PLoS One; 2022; 17(10):e0267423. PubMed ID: 36201406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.